Table 2.
Timeline for HypoPAST randomised controlled trial
| Baseline: pre-randomisation | Implementation | End-trial | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Week: | -2 | -1 | 0 | 1 to 11 | 12 | 13 to 23 | 24 | 25 | 26+ |
| Screening, registration, randomisation | |||||||||
| Consent and registration, eligibility screening survey | X | ||||||||
| Randomisation | X | ||||||||
| Implementation | |||||||||
| Intervention or usual care | X | ||||||||
| Intervention access expires (intervention group) | X | ||||||||
| Data collection | |||||||||
| Surveysa | X | X | X | ||||||
| EMA daily check-ins (twice per day for 2 weeks)b | X | X | |||||||
| Website analytics | X | ||||||||
| Semi-structured interviewc | X | ||||||||
aParticipants are encouraged to complete the online survey immediately upon receiving the hyperlink, however the surveys will remain open for three weeks to allow for late completion
bBaseline EMA will commence after the baseline survey is returned
cApproximate timing. Interviews will be scheduled after the participant returns their end-trial survey/EMA data, or after the window for survey/EMA data return closes (whichever occurs first)